Viewing StudyNCT00052130

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00052130
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2003-01-22
Brief Title: Vaccine Therapy for Patients With Stage III Melanoma
Sponsor: CancerVax Corporation
Organization: CancerVax Corporation
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Malignant Melanoma
Keywords: